文献速递类风湿关节炎

Semaphorins:从血管生成到类风湿关节炎炎症的作用

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2021-08-06

该研究通过微阵列分析类风湿关节炎(RA)内皮细胞(ECs)与对照ECs,发现第3、4类semaphorins及其受体差异表达,SEMA4A、plexin D1和neuropilin 1 mRNA在RA ECs中分别增加1.75、2.21和1.68倍。TNF刺激使RA ECs中SEMA4A mRNA增加2倍,且SEMA4A缺陷改变RA EC血管生成特性。RA滑膜组织中semaphorins及其受体过表达,血清中SEMA4A和SEMA3E分别增加1.30和1.54倍,SEMA3A降低24%。SEMA4A、SEMA4D和SEMA3A血清水平与炎症和促血管生成标志物相关,SEMA4A可识别低疾病活动度或缓解期RA患者的残余疾病活动。结论:第3、4类semaphorins可能成为RA的生物标志物和治疗靶点。

要点

  • RA内皮细胞中SEMA4A、plexin D1和neuropilin 1 mRNA分别增加1.75、2.21和1.68倍。
  • TNF刺激使RA内皮细胞SEMA4A mRNA增加2倍,SEMA4A缺陷改变血管生成特性。
  • 血清SEMA4A和SEMA3E分别增加1.30和1.54倍,SEMA3A降低24%,与炎症标志物相关。

核心结论

  • 第3、4类semaphorins在RA内皮细胞、滑膜血管和血清中过表达,并与炎症和血管生成标志物相关,可能成为RA的生物标志物和治疗靶点。

研究设计与样本

  • 在RA内皮细胞和对照内皮细胞中进行Affymetrix GeneChip Human Exon 1.0 ST阵列微阵列实验,并通过免疫组化分析和酶联免疫吸附试验评估RA患者和健康对照血清中第3、4类semaphorins及其受体的表达。

主要发现

  • 微阵列分析显示RA内皮细胞中第3、4类semaphorins及其受体差异表达,SEMA4A、plexin D1和neuropilin 1 mRNA分别增加1.75、2.21和1.68倍。
  • TNF刺激使RA内皮细胞中SEMA4A mRNA增加2倍,SEMA4A缺陷改变RA内皮细胞血管生成特性。
  • RA滑膜组织中第3、4类semaphorins及其受体过表达;血清中SEMA4A和SEMA3E分别增加1.30和1.54倍,SEMA3A降低24%。
  • 血清SEMA4A、SEMA4D和SEMA3A水平与炎症和促血管生成标志物水平相关。
  • 在两个独立队列中,低疾病活动度或缓解期RA患者中SEMA4A的存在可识别残余疾病活动。

关键数值与推荐

  • RA内皮细胞中SEMA4A、plexin D1和neuropilin 1 mRNA分别增加1.75、2.21和1.68倍。
  • TNF刺激使RA内皮细胞SEMA4A mRNA增加2倍。
  • RA患者血清中SEMA4A和SEMA3E分别增加1.30和1.54倍,SEMA3A降低24%。

临床怎么用

  • SEMA4A、SEMA4D和SEMA3A血清水平与炎症和促血管生成标志物相关,SEMA4A可用于识别低疾病活动度或缓解期RA患者的残余疾病活动。
  • 第3、4类semaphorins可能作为内皮细胞来源的炎症和促血管生成靶点,用于RA的生物标志物和治疗开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the potential role of semaphorins in the pathogenesis of rheumatoid arthritis (RA). METHODS: Microarray experiments were performed on Affymetrix GeneChip Human Exon 1.0 ST arrays in RA endothelial cells (ECs) and control ECs derived from circulating progenitors. Expression of class 3 and class 4 semaphorins and their receptors in the serum of RA patients and healthy controls was assessed by immunohistochemical analysis in synovial tissue and by enzyme-linked immunosorbent assay. RESULTS: Microarray analysis revealed differential expression of class 3 and class 4 semaphorins and their receptors in RA ECs. Semaphorin 4A (SEMA4A), plexin D1, and neuropilin 1 messenger RNA (mRNA) levels were markedly increased in RA ECs by 1.75-, 2.21-, and 1.68-fold, respectively. Stimulation with tumor necrosis factor (TNF) led to a 2-fold increase in SEMA4A mRNA levels in RA ECs, and deficient SEMA4A expression modified RA EC angiogenic properties. Class 3 and class 4 semaphorins as well as their receptors were overexpressed in RA synovial tissue. A respective 1.30-fold increase and 1.54-fold increase in SEMA4A and SEMA3E, as well as a 24% decrease in SEMA3A, was observed in the serum of RA patients. Serum levels of SEMA4A, SEMA4D, and SEMA3A correlated with levels of inflammation and proangiogenic markers. In 2 independent cohorts of patients with low disease activity or with RA in remission, the presence of SEMA4A identified patients with residual disease activity. CONCLUSION: Gene expression profiling of ECs identified class 3 and class 4 semaphorins as potential biomarkers and therapeutic candidates in RA, with confirmed overexpression in ECs, synovial vessels, and serum, and correlation with validated markers of inflammation and angiogenesis. Thus, semaphorins might be novel and appealing EC-derived inflammatory and proangiogenic targets in RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Avouac J, Pezet S, Vandebeuque E, et al. Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33605067. doi:10.1002/art.41701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。